BEAT - BioTelemetry, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
430,676
399,472
286,776
208,332
Cost of Revenue
162,373
148,986
114,406
78,882
Gross Profit
268,303
250,486
172,370
129,450
Operating Expenses
Research Development
13,281
11,206
11,101
8,355
Selling General and Administrative
163,917
152,585
118,305
84,513
Total Operating Expenses
175,405
163,791
129,406
92,868
Operating Income or Loss
92,898
86,695
42,964
36,582
Interest Expense
9,805
9,429
4,897
-
Total Other Income/Expenses Net
-35,677
-35,762
-48,463
-18,570
Income Before Tax
47,416
41,504
-10,396
15,770
Income Tax Expense
8,755
-370
6,747
-37,667
Income from Continuing Operations
38,661
41,874
-17,143
53,437
Net Income
38,661
42,820
-15,956
53,437
Net Income available to common shareholders
38,661
42,820
-15,956
53,437
Reported EPS
Basic
-
1.31
-0.53
1.91
Diluted
-
1.20
-0.53
1.75
Weighted average shares outstanding
Basic
-
32,709
30,386
27,920
Diluted
-
35,783
30,386
30,489
EBITDA
-
50,933
-5,499
36,582